Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1211523-71-5 | MDL No. : | MFCD10000072 |
Formula : | C7H5BrN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZELUAAXEWIYSLH-UHFFFAOYSA-N |
M.W : | 197.03 | Pubchem ID : | 53403509 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 41.46 |
TPSA : | 36.68 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.42 cm/s |
Log Po/w (iLOGP) : | 1.48 |
Log Po/w (XLOGP3) : | 1.53 |
Log Po/w (WLOGP) : | 1.91 |
Log Po/w (MLOGP) : | 0.89 |
Log Po/w (SILICOS-IT) : | 2.31 |
Consensus Log Po/w : | 1.62 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.4 |
Solubility : | 0.778 mg/ml ; 0.00395 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.91 |
Solubility : | 2.43 mg/ml ; 0.0123 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.37 |
Solubility : | 0.0837 mg/ml ; 0.000425 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.86 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | at 20℃; Inert atmosphere | A solution of (2-bromopyridin-3-yl) methyl methanesulfonate 2 (200 mg, 0.75 mmol) and NaCN (0.18 g, 3.75 mmol) in DMSO (2 mL) was stirred overnight at room temperature. Ethylacetate (10 mL) was then added. The resulting solution was washed with water (3X10 mL) then extracted with ethylacetate (3X10 mL). The organic layer was dried over MgSO4 then evaporated to yield a brown oil which was filtered through a short pad of silica with diethylether to give compound 3 as white crystals (95percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
2.21 g | Stage #1: With potassium <i>tert</i>-butylate In 1,2-dimethoxyethane at -60℃; for 1 h; Stage #2: With methanol In 1,2-dimethoxyethane at 20 - 85℃; for 2 h; |
To a -60 °C mixture of t-BuOK (5.92 g, 52.76 mmol) in 1,2-dimethoxyethane (50 mL)was added a solution of 2-tosylacetonitrile (5.08 g, 26.02 mmol) in 1,2-dimethoxyethane (20 mL)dropwise. To the resulting mixture was added a solution of 2-bromonicotinaldehyde (4.81 g, 25.86 mmol) in 1 ,2-dimethoxyethane (20 mL) dropwise at -60 °C. After stirring for 1 h at thistemperature, MeOH was added (50 mL), the resulting mixture was allowed to warm to RT, stirred for 1 h and warmed to 85 °C, stirred for another lh. After cooling to RT, the volatiles was removedunder reduced pressure, diluted with brine (200 mL) and extracted with EA (3 x 150 mL). Thecombined organic layers were dried over anhydrous Na2504, filtered and concentrated underreduced pressure. The residue was purified by silica chromatography (eluting with EA: Hex = 1:10, v/v) to give 2-(2-bromopyridin-3-yl)acetonitrile (2.21 g). MS: m/z 197 (M+H) . |
[ 65996-18-1 ]
2-Bromo-5-methylnicotinonitrile
Similarity: 0.78
[ 116986-13-1 ]
3-(Bromomethyl)picolinonitrile
Similarity: 0.78